Kate Cwynarski

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · The Lancet Haematology · 2016 · 599 citations · Full text

Medicine, Immunology, Oncology +12

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · The Lancet Haematology · 2017 · 381 citations · Full text

Medicine, Immunology, Oncology +17

Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation

Kate Cwynarski, Jenni Ainsworth, Mark Cobbold et al. · Blood · 2001 · 294 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

Francesco Dazzi, Richard Szydlo, Nicholas C.P. Cross et al. · Blood · 2000 · 266 citations · Full text

Medicine, Hematology, Immunology +13

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report

Lucy Cook, Shigeo Fuji, Olivier Hermine et al. · Journal of Clinical Oncology · 2019 · 257 citations · Full text

Medicine, Molecular Medicine, Oncology +14